VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Age from 40 to 80 years old, either gender         │ Age from 40 to 80 years old, either gender         │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Patients with bilateral age related cataracts,     │ Patients with bilateral age related cataracts,     │     100 │
│ require bilateral cataract phacoemulsification     │ require bilateral cataract phacoemulsification     │         │
│ combined Intraocular Lens implantation             │ combined Intraocular Lens implantation             │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Willing to undergo second eye surgery within 7     │ Willing to undergo second eye surgery within 7     │     100 │
│ days after first eye surgery                       │ days after first eye surgery                       │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ The potential postoperative visual acuity of 20/40 │ The potential postoperative visual acuity of 20/40 │     100 │
│ or better in both eyes                             │ or better in both eyes                             │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Preoperative measurement of corneal astigmatism    │ Preoperative measurement of corneal astigmatism    │     100 │
│ indicate the subjects are suitable for multifocal  │ indicate the subjects are suitable for multifocal  │         │
│ intraocular lenses implantation                    │ intraocular lenses implantation                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Capability to understand the informed consent and  │ Capability to understand the informed consent and  │     100 │
│ willing and able to attend study                   │ willing and able to attend study                   │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Preexisting ocular diseases or conditions other    │ Preexisting ocular diseases or conditions other    │     100 │
│ than age related cataracts, have contraindications │ than age related cataracts, have contraindications │         │
│ for cataract surgery                               │ for cataract surgery                               │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Preexisting systemic diseases or conditions that   │ Preexisting systemic diseases or conditions that   │     100 │
│ may confound the results of the study              │ may confound the results of the study              │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Previous ocular surgery history or ocular trauma   │ Previous ocular surgery history or ocular trauma   │     100 │
│ that may confound the results of the study         │ that may confound the results of the study         │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Require combined surgery that may confound the     │ Require combined surgery that may confound the     │     100 │
│ results of the study                               │ results of the study                               │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Previous participation in other clinical trial     │ Previous participation in other clinical trial     │     100 │
│ within 30 days of this study start                 │ within 30 days of this study start                 │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Systemic or ocular medications that may confound   │ Systemic or ocular medications that may confound   │     100 │
│ the outcome of the intervention                    │ the outcome of the intervention                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Pregnant, lactating, or planning to become         │ Pregnant, lactating, or planning to become         │     100 │
│ pregnant during the course of the trial            │ pregnant during the course of the trial            │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria                                      │   Score │
╞═══════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Must have maximum age of 80 Years │ Age from 40 to 80 years old, either gender         │      37 │
├───────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Must have minimum age of 40 Years │ The potential postoperative visual acuity of 20/40 │      38 │
│                                   │ or better in both eyes                             │         │
╘═══════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 97
Average Levenshtein Ratio of individual lines: 91.66666666666667
OverAll Ratio: 94.33333333333334
